These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 9093738)
21. Norepinephrine does not potentiate porcine malignant hyperthermia. Maccani RM; Wedel DJ; Hofer RE Anesth Analg; 1996 Apr; 82(4):790-5. PubMed ID: 8615499 [TBL] [Abstract][Full Text] [Related]
22. Malignant hyperthermia during pediatric kidney transplantation-A medical and ethical quandary. Srinivasan SP; Eldo N; Nair SG Pediatr Transplant; 2021 May; 25(3):e13923. PubMed ID: 33314641 [TBL] [Abstract][Full Text] [Related]
23. Malignant hyperthermia. Miranda AD; Donovan LA; Schuster LL; Gerber DR Am J Crit Care; 1997 Sep; 6(5):368-74; quiz 375-6. PubMed ID: 9283674 [TBL] [Abstract][Full Text] [Related]
24. Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry. Litman RS; Flood CD; Kaplan RF; Kim YL; Tobin JR Anesthesiology; 2008 Nov; 109(5):825-9. PubMed ID: 18946294 [TBL] [Abstract][Full Text] [Related]
26. [Malignant hyperthermia. The ugly]. Rüffert H; Wehner M; Deutrich C; Olthoff D Anaesthesist; 2007 Sep; 56(9):923-9. PubMed ID: 17565473 [TBL] [Abstract][Full Text] [Related]
27. [Hypercapnia and mixed acidosis as the only sign of malignant hyperthermia (MH)?]. Wanke-Jellinek C; Missaghi SM; Czech K Anaesthesist; 1994 Aug; 43(8):553-6. PubMed ID: 7978180 [TBL] [Abstract][Full Text] [Related]
28. Porcine malignant hyperthermia: critical temperatures for in vivo and in vitro responses. Nelson TE Anesthesiology; 1990 Sep; 73(3):449-54. PubMed ID: 2393129 [TBL] [Abstract][Full Text] [Related]
35. Differential diagnosis of thyroid crisis and malignant hyperthermia in an anesthetized porcine model. Shailesh Kumar MV; Carr RJ; Komanduri V; Reardon RF; Beebe DS; Iaizzo PA; Belani KG Endocr Res; 1999 Feb; 25(1):87-103. PubMed ID: 10098596 [TBL] [Abstract][Full Text] [Related]
36. Current understanding of malignant hyperthermia: genesis, prevention, and treatment. Katz DN CRNA; 1992 May; 3(2):54-63. PubMed ID: 1483145 [TBL] [Abstract][Full Text] [Related]
37. Current concepts of malignant hyperthermia. Jafek BW; Solomons CC; Masson NC; Mahowald MC; Gumprecht TF Otolaryngol Head Neck Surg; 1981; 89(6):891-7. PubMed ID: 6801585 [TBL] [Abstract][Full Text] [Related]
38. Suspected malignant hyperthermia in a child with laminin alpha2 (merosin) deficiency in the absence of a triggering agent. Shukry M; Guruli ZV; Ramadhyani U Paediatr Anaesth; 2006 Apr; 16(4):462-5. PubMed ID: 16618304 [TBL] [Abstract][Full Text] [Related]
39. Malignant hyperthermia in Mazovia Province - are we adequately prepared? Cieniewicz A; Trzebicki J Anaesthesiol Intensive Ther; 2022; 54(2):99-102. PubMed ID: 35579281 [TBL] [Abstract][Full Text] [Related]
40. Use of vecuronium and doxapram in patients susceptible to malignant hyperthermia. Ording H; Fonsmark L Br J Anaesth; 1988 Mar; 60(4):445-9. PubMed ID: 2895665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]